161 related articles for article (PubMed ID: 32321466)
1. Broadening risk profile in familial colorectal cancer type X; increased risk for five cancer types in the national Danish cohort.
Therkildsen C; Rasmussen M; Smith-Hansen L; Kallemose T; Lindberg LJ; Nilbert M
BMC Cancer; 2020 Apr; 20(1):345. PubMed ID: 32321466
[TBL] [Abstract][Full Text] [Related]
2. Frequency of extra-colonic tumors in hereditary nonpolyposis colorectal cancer (HNPCC) and familial colorectal cancer (FCC) Brazilian families: An analysis by a Brazilian Hereditary Colorectal Cancer Institutional Registry.
Oliveira Ferreira F; Napoli Ferreira CC; Rossi BM; Toshihiko Nakagawa W; Aguilar S; Monteiro Santos EM; Vierira Costa ML; Lopes A
Fam Cancer; 2004; 3(1):41-7. PubMed ID: 15131405
[TBL] [Abstract][Full Text] [Related]
3. Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X.
Lindor NM; Rabe K; Petersen GM; Haile R; Casey G; Baron J; Gallinger S; Bapat B; Aronson M; Hopper J; Jass J; LeMarchand L; Grove J; Potter J; Newcomb P; Terdiman JP; Conrad P; Moslein G; Goldberg R; Ziogas A; Anton-Culver H; de Andrade M; Siegmund K; Thibodeau SN; Boardman LA; Seminara D
JAMA; 2005 Apr; 293(16):1979-85. PubMed ID: 15855431
[TBL] [Abstract][Full Text] [Related]
4. Hereditary colorectal cancer diagnostics: morphological features of familial colorectal cancer type X versus Lynch syndrome.
Klarskov L; Holck S; Bernstein I; Nilbert M
J Clin Pathol; 2012 Apr; 65(4):352-6. PubMed ID: 22287689
[TBL] [Abstract][Full Text] [Related]
5. Risk of gynecologic cancers in Danish hereditary non-polyposis colorectal cancer families.
Boilesen AE; Bisgaard ML; Bernstein I
Acta Obstet Gynecol Scand; 2008; 87(11):1129-35. PubMed ID: 18972272
[TBL] [Abstract][Full Text] [Related]
6. Suspected hereditary nonpolyposis colorectal cancer: International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC) criteria and results of genetic diagnosis.
Park JG; Vasen HF; Park KJ; Peltomaki P; Ponz de Leon M; Rodriguez-Bigas MA; Lubinski J; Beck NE; Bisgaard ML; Miyaki M; Wijnen JT; Baba S; Lynch HT
Dis Colon Rectum; 1999 Jun; 42(6):710-5; discussion 715-6. PubMed ID: 10378593
[TBL] [Abstract][Full Text] [Related]
7. Characterisation of familial colorectal cancer Type X, Lynch syndrome, and non-familial colorectal cancer.
Shiovitz S; Copeland WK; Passarelli MN; Burnett-Hartman AN; Grady WM; Potter JD; Gallinger S; Buchanan DD; Rosty C; Win AK; Jenkins M; Thibodeau SN; Haile R; Baron JA; Marchand LL; Newcomb PA; Lindor NM;
Br J Cancer; 2014 Jul; 111(3):598-602. PubMed ID: 24918813
[TBL] [Abstract][Full Text] [Related]
8. Clinical heterogeneity of familial colorectal cancer and its influence on screening protocols.
Vasen HF; Taal BG; Griffioen G; Nagengast FM; Cats A; Menko FH; Oskam W; Kleibeuker JH; Offerhaus GJ; Khan PM
Gut; 1994 Sep; 35(9):1262-6. PubMed ID: 7959234
[TBL] [Abstract][Full Text] [Related]
9. Screening for urinary tract cancer with urine cytology in Lynch syndrome and familial colorectal cancer.
Myrhøj T; Andersen MB; Bernstein I
Fam Cancer; 2008; 7(4):303-7. PubMed ID: 18389386
[TBL] [Abstract][Full Text] [Related]
10. Frequency of hereditary non-polyposis colorectal cancer in Danish colorectal cancer patients.
Katballe N; Christensen M; Wikman FP; Ørntoft TF; Laurberg S
Gut; 2002 Jan; 50(1):43-51. PubMed ID: 11772966
[TBL] [Abstract][Full Text] [Related]
11. The tumour spectrum in hereditary non-polyposis colorectal cancer: a study of 24 kindreds in the Netherlands.
Vasen HF; Offerhaus GJ; den Hartog Jager FC; Menko FH; Nagengast FM; Griffioen G; van Hogezand RB; Heintz AP
Int J Cancer; 1990 Jul; 46(1):31-4. PubMed ID: 2365499
[TBL] [Abstract][Full Text] [Related]
12. A population-based study of hereditary non-polyposis colorectal cancer: evidence of pathologic and genetic heterogeneity.
Warden G; Harnett D; Green J; Wish T; Woods MO; Green R; Dicks E; Rahman P; Zhai G; Parfrey P
Clin Genet; 2013 Dec; 84(6):522-30. PubMed ID: 23278430
[TBL] [Abstract][Full Text] [Related]
13. Towards gene- and gender-based risk estimates in Lynch syndrome; age-specific incidences for 13 extra-colorectal cancer types.
Therkildsen C; Ladelund S; Smith-Hansen L; Lindberg LJ; Nilbert M
Br J Cancer; 2017 Nov; 117(11):1702-1710. PubMed ID: 29065108
[TBL] [Abstract][Full Text] [Related]
14. Familial risk of tumors associated with hereditary non-polyposis colorectal cancer: a Swedish population-based study.
Ericson K; Nilbert M; Bladström A; Anderson H; Olsson H; Planck M
Scand J Gastroenterol; 2004 Dec; 39(12):1259-65. PubMed ID: 15743004
[TBL] [Abstract][Full Text] [Related]
15. Atypical HNPCC owing to MSH6 germline mutations: analysis of a large Dutch pedigree.
Wagner A; Hendriks Y; Meijers-Heijboer EJ; de Leeuw WJ; Morreau H; Hofstra R; Tops C; Bik E; Bröcker-Vriends AH; van Der Meer C; Lindhout D; Vasen HF; Breuning MH; Cornelisse CJ; van Krimpen C; Niermeijer MF; Zwinderman AH; Wijnen J; Fodde R
J Med Genet; 2001 May; 38(5):318-22. PubMed ID: 11333868
[TBL] [Abstract][Full Text] [Related]
16. Familial Colorectal Cancer Type X (FCCTX) and the correlation with various genes-A systematic review.
Nejadtaghi M; Jafari H; Farrokhi E; Samani KG
Curr Probl Cancer; 2017; 41(6):388-397. PubMed ID: 29096939
[TBL] [Abstract][Full Text] [Related]
17. Familial colorectal cancer type X syndrome: two distinct molecular entities?
Francisco I; Albuquerque C; Lage P; Belo H; Vitoriano I; Filipe B; Claro I; Ferreira S; Rodrigues P; Chaves P; Leitão CN; Pereira AD
Fam Cancer; 2011 Dec; 10(4):623-31. PubMed ID: 21837511
[TBL] [Abstract][Full Text] [Related]
18. Disease expression in Swiss hereditary non-polyposis colorectal cancer (HNPCC) kindreds.
Heinimann K; Müller H; Weber W; Scott RJ
Int J Cancer; 1997 Jun; 74(3):281-5. PubMed ID: 9221805
[TBL] [Abstract][Full Text] [Related]
19. Risk of gastric cancer in hereditary nonpolyposis colorectal cancer in Korea.
Park YJ; Shin KH; Park JG
Clin Cancer Res; 2000 Aug; 6(8):2994-8. PubMed ID: 10955776
[TBL] [Abstract][Full Text] [Related]
20. Urinary Tract Cancer in Lynch Syndrome; Increased Risk in Carriers of MSH2 Mutations.
Joost P; Therkildsen C; Dominguez-Valentin M; Jönsson M; Nilbert M
Urology; 2015 Dec; 86(6):1212-7. PubMed ID: 26385421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
